GLENMEDE TRUST CO NA

Bank

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 314949 PHILADELPHIA, PA

Position in JAZZ

as of Mar 31, 2026 · filed May 26, 2026 Compact

Position Value

$1,478,181

+$173,771 QoQ

Shares Held

7,819

+1.9% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 92.90190561452872.ToString("F0")% Shared 0.ToString("F0")% None 7.0980943854712875.ToString("F0")%

Healthcare · as of Mar 31, 2026

GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. JAZZ ranks #7 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	523,291	$49,252,148
2	CPRX	Catalyst Pharmaceuticals, Inc.	565,424	$13,999,896
3	REGN	Regeneron Pharmaceuticals, Inc.	18,059	$13,953,104
4	HALO	Halozyme Therapeutics, Inc.	146,717	$9,482,319
5	ACAD	Acadia Pharmaceuticals Inc	405,892	$9,035,155
6	VRTX	Vertex Pharmaceuticals Inc / Ma	5,608	$2,504,195
7	JAZZ	Jazz Pharmaceuticals plc This page	7,819	$1,478,181
8	AXSM	Axsome Therapeutics, Inc.	6,716	$1,135,138

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,478,181	7,819	+1.9%	Shares	Sole	2026-05-26
2025-12-31	$1,304,410	7,673	+182.7%	Shares	Sole	2026-02-17
2021-09-30	$353,389	2,714	-92.3%	Shares	Sole	2021-11-15
2021-06-30	$6,302,133	35,477	+7.6%	Shares	Defined	2021-08-16
2021-03-31	$5,421,742	32,985	-17.9%	Shares	Defined	2021-05-18
2020-12-31	$6,635,008	40,200	+14.3%	Shares	Sole	2021-02-16
2020-09-30	$5,014,317	35,166	+2.1%	Shares	Defined	2020-11-16
2020-06-30	$3,798,894	34,429	-72.4%	Shares	Sole	2020-08-14
2020-03-31	$12,438,375	124,708	—	Shares	Sole	2020-05-20
No filing history on record for this holder in this stock.